You are here

Merck

3 Tremendously Promising Diabetes Drugs Potentially on the Way

Motley Fool

Sun, 03/26/17 - 12:02 pm

Lexicon Pharmaceuticals

Merck's Keytruda Gets CHMP Nod for Lymphoma

Investopedia

Sat, 03/25/17 - 12:12 pm

Hodgkin's lymphoma

That $95M Merck gamble to acquire cCAM? It didn’t pay off.

Endpoints

Fri, 03/24/17 - 10:10 am

Roger Perlmutter

Merck Animal Health Completes Acquisition of Vallée S.A.

Yahoo

Thu, 03/23/17 - 09:23 am

Merck Animal Health

Court Revives Claims Against Merck Osteoporosis Drug

Investopedia

Wed, 03/22/17 - 10:30 pm

thigh fractures

FDA OKs Merck’s Keytruda for Hodgkin lymphoma, a first in blood cancer

Endpoints

Wed, 03/15/17 - 11:24 am

Hodgkin's lymphoma

Zostavax patients sue Merck, claiming shingles shot caused injuries and death

Fierce Pharma

Tue, 03/14/17 - 04:38 pm

Merck and Pfizer prep for battle with SGLT2, combo diabetes filings

Fierce Pharma

Mon, 03/13/17 - 10:18 am

SGLT2 inhibitor

Boehringer Ingelheim

Merck aims to put Amazon's Alexa to work on voice-enabled diabetes tools

Fierce Pharma

Wed, 03/8/17 - 09:46 am

Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition

Endpoints

Tue, 03/7/17 - 11:55 am

type 2 diabetes

GSK's vaccines access leads the pack, report says, as lagging Pfizer disputes findings

Fierce Pharma

Tue, 03/7/17 - 10:28 am

Drug for Dust Mite Allergy Approved by FDA

Xtalks

Fri, 03/3/17 - 10:27 pm

Report: Why Merck turned to supply chain integration to save costs

BioPharma Dive

Thu, 03/2/17 - 03:44 pm

supply chain integration

drug manufacturing

Big Pharma Is Losing a Fortune Trying to Cure Alzheimer's

Bloomberg

Thu, 03/2/17 - 10:16 am

Alzheimer's disease

drug development

Big Pharma Pushes Back on Drug-Price Complaints

Investopedia

Wed, 03/1/17 - 09:22 pm

Januvia, Vaccines May Drive Merck’s Revenue Growth in 2017

Market Realist

Tue, 02/28/17 - 11:52 pm

Merck May Witness Flat Revenue Growth in 2017

Market Realist

Mon, 02/27/17 - 10:04 pm

Pharma heads write to Congress... and put foot in mouth

Forbes

Sun, 02/26/17 - 12:57 pm

Merck tees up US/European applications for letermovir after detailing PhIII antiviral success

Endpoints

Sun, 02/26/17 - 12:50 pm

clinical trials

In First Phase 3 Trial, Merck’s Investigational Inactivated Varicella Zoster Virus Vaccine (V212) Reduced the Incidence of Confirmed Herpes Zoster Cases by an Estimated 64 Percent in Immunocompromised Subjects

Yahoo

Sat, 02/25/17 - 02:00 pm

varicella zoster

Pages